Latest Continuous Disclosure News

Bindi Metals Limited’s BIMO securities have been suspended from ASX quotation due to non-compliance with listing rules, raising questions about the company’s regulatory standing.

Tissue Repair Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, denying any undisclosed information and confirming compliance with listing rules.

Orion Minerals has responded to an ASX price query following a recent uptick in its share price, confirming no undisclosed material information exists while highlighting ongoing financing talks with Glencore.

Osmond Resources has affirmed the materiality of recent drilling results at its Orión EU Critical Minerals Project in Spain, clarifying the timing of its disclosures following ASX inquiries. The findings suggest a potentially large-scale heavy mineral deposit rich in valuable minerals.

OD6 Metals has responded to an ASX price query following a notable rise in its share price and trading volume, confirming no undisclosed information exists and attributing the market activity to an independent research report.

Cokal Limited has clarified the recent spike in its share price and trading volume, attributing the market activity to a series of operational milestones and strategic partnerships rather than undisclosed information.

Australian Ethical Investment Limited (AEF) has responded to ASX inquiries about additional licence conditions imposed on its subsidiary, Australian Ethical Superannuation Pty Ltd (AES), asserting these do not materially affect its securities value despite a notable share price drop.

ActivePort Group Ltd is launching a pro-rata bonus option offer, granting shareholders 1 option per 5 shares held, exercisable at $0.04 and expiring in 2028. While no immediate funds will be raised, full exercise could inject over $9 million into the company.

MEC Resources Ltd has announced a placement of over 359 million new options to raise approximately $359,000, with directors participating to offset fees. The offer comes as the company navigates ongoing legal challenges related to its key PEP-11 permit.

Proteomics International Laboratories has clarified that no undisclosed information explains its recent share price jump, pointing instead to recent Medicare reimbursement decisions and key product developments.

Vitasora Health has secured AU$3.56 million from a cornerstone investor, issuing over 118 million shares, while confirming compliance with key regulatory disclosure obligations.

VanEck Investments Limited has released an updated Product Disclosure Statement detailing its suite of Australian fixed income ETFs, outlining fund strategies, risk factors, and fee structures.